Literature DB >> 19744718

Proposed diagnostic criteria for obstructive meibomian gland dysfunction.

Reiko Arita1, Kouzo Itoh, Syuji Maeda, Koshi Maeda, Ayumu Furuta, Shima Fukuoka, Atsuo Tomidokoro, Shiro Amano.   

Abstract

PURPOSE: To compare clinical findings between patients with obstructive meibomian gland dysfunction (MGD) and normal controls and to propose diagnostic criteria for obstructive MGD.
DESIGN: Cross-sectional, observational case series. PARTICIPANTS: Fifty-three eyes of 53 patients (18 men, 35 women; age [mean +/- standard deviation] 71.4 +/- 10.0 years) who were diagnosed with obstructive MGD and 60 eyes of 60 healthy volunteers (22 men, 38 women; 71.0 +/- 9.3 years) as a control group.
METHODS: Ocular symptoms were scored from 0 to 14 according to the number of existing symptoms. Lid margin abnormality was scored from 0 to 4 depending on the number of existing abnormalities. Meibomian gland changes were scored from 0 to 6 based on noncontact meibography (meibo-score). Superficial punctuate keratopathy (SPK) was scored from 0 to 3. Meibum was graded from 0 to 3 depending on the volume and quality. Tear film production was evaluated by Schirmer's test. Receiver operating characteristic curves with calculations of area under the curve (AUC) were used to describe the accuracy of each parameter to differentiate obstructive MGD from normal eyes. MAIN OUTCOME MEASURES: Ocular symptom score, lid margin abnormality score, meibo-score, meibum score, SPK score, tear film breakup time (BUT), and the Schirmer value.
RESULTS: Ocular symptom score, lid margin abnormality score, meibo-score, meibum score, and SPK score were significantly higher in the obstructive MGD group than in the control group (P<0.0001 for all scores). The BUT was significantly shorter in the obstructive MGD group than in the control group (P<0.0001). The AUC values indicated that the ocular symptom score had the highest diagnostic power as a single parameter, followed by the lid margin abnormality score, meibo-score, and BUT.
CONCLUSIONS: Based on these findings, we recommend that physicians use the ocular symptom score, lid margin abnormality score, and meibo-score to diagnose MGD. Obstructive MGD should be suspected when any 2 of the 3 scores are abnormal. Obstructive MGD is very likely when all 3 scores are abnormal.

Entities:  

Mesh:

Year:  2009        PMID: 19744718     DOI: 10.1016/j.ophtha.2009.04.037

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  82 in total

1.  Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye.

Authors:  Reiko Arita; Kouzo Itoh; Syuji Maeda; Koshi Maeda; Atsuo Tomidokoro; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

2.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

3.  Meibomian gland loss due to trabeculectomy.

Authors:  Hideto Sagara; Tetsuju Sekiryu; Hiroki Noji; Masashi Ogasawara; Yukinori Sugano; Hiroko Horikiri
Journal:  Jpn J Ophthalmol       Date:  2014-05-24       Impact factor: 2.447

Review 4.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 5.  The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.

Authors:  J Daniel Nelson; Jun Shimazaki; Jose M Benitez-del-Castillo; Jennifer P Craig; James P McCulley; Seika Den; Gary N Foulks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

6.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study.

Authors:  Ebenezer Daniel; Maureen G Maguire; Maxwell Pistilli; Vatinee Y Bunya; Giacomina M Massaro-Giordano; Eli Smith; Pooja A Kadakia; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-04-22       Impact factor: 5.033

7.  Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients.

Authors:  Maierhaba Yusufu; Xin Liu; Tianyu Zheng; Fan Fan; Jianjiang Xu; Yi Luo
Journal:  Int Ophthalmol       Date:  2017-07-11       Impact factor: 2.031

Review 8.  Characterization of expressed human meibum using hyperspectral stimulated Raman scattering microscopy.

Authors:  Jerry R Paugh; Alba Alfonso-Garcia; Andrew Loc Nguyen; Jeffrey L Suhalim; Marjan Farid; Sumit Garg; Jeremiah Tao; Donald J Brown; Eric O Potma; James V Jester
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

9.  A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction.

Authors:  Yuanyuan Qi; Chen Zhang; Shaozhen Zhao; Yue Huang; Ruibo Yang
Journal:  Exp Ther Med       Date:  2017-04-19       Impact factor: 2.447

10.  Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction.

Authors:  Yu-Fei Gao; Rong-Jun Liu; Ya-Xin Li; Chenmilu Huang; Yi-Yun Liu; Chen-Xi Hu; Hong Qi
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.